// App-Quantinova.ai

552 : Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Adults With Philadelphia Chromosome (Ph)-Negative Acute Lymphoblastic Leukemia (ALL): Results From The Group For Research On Adult ALL (GRAALL)

Researchers

Presenter

  • Nathalie Dhedin

Principal Investigators

  • Sebastien Maury

  • Martine Escoffre-Barbe

  • Oumedaly Reman

  • Yves Chalandon

  • Didier Blaise

  • Nicole Raus

  • Veronique Lheritier

  • Jean-Yves Cahn

  • Herve Dombret

  • Norbert Ifrah

  • Reza Tabrizi

  • Xavier Thomas

  • Patrice Chevallier

  • Stephanie Nguyen

  • Valerie Coiteux

  • Mathilde Hunault

  • Stephane de Botton

  • Yosr Hichri

Medical Centers

  • Hematology, CHU, Angers, France

  • Hematology, Hopital Pitie-Salptriere, Paris, France

  • Centre of Oncology, Geneva University Hospital, Geneva, Switzerland

  • Service dHematologie, Gustave Roussy Cancer Center, Villejuif, France

  • Centre Hospitalier Lyon-Sud, Pierre-Benite, France

  • Hematology, CHU Rennes, Rennes, France

  • Hematology, Bordeaux, France

  • Service des Maladies du Sang, Hopital Claude Huriez, Lille, France

  • Unite Adolescents et Jeunes Adultes, Saint Louis Hospital, Paris, France

  • Hematology, Hopital Henri Mondor, Creteil Cedex, France

  • Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France

  • Hematology, CHU, Angers, France

  • Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC), Lyon, France

  • Hematology, CHU, Angers, France

  • Hematology, University Hospital of Toulouse, Toulouse, France

  • Hematology, CHUV, Montpellier, France

  • Coordination, Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL), Lyon, France

  • Department of Hematology, Grenoble University Hospital, Grenoble, France

  • Hospital Saint Antoine, Paris, France

Locations

  • France

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Histone-lysine N-methyltransferase 2A

  • T-cell receptor

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim